Murphy Kaitlin C, Hughbanks Marissa L, Binder Bernard Y K, Vissers Caroline B, Leach J Kent
Department of Biomedical Engineering, University of California, Davis, Davis, CA, 95616, USA.
Ann Biomed Eng. 2015 Aug;43(8):2010-21. doi: 10.1007/s10439-014-1227-x. Epub 2014 Dec 20.
Mesenchymal stem/stromal cells (MSCs) are under examination for use in cell therapies to repair bone defects resulting from trauma or disease. MSCs secrete proangiogenic cues and can be induced to differentiate into bone-forming osteoblasts, yet there is limited evidence that these events can be achieved in parallel. Manipulation of the cell delivery vehicle properties represents a candidate approach for directing MSC function in bone healing. We hypothesized that the biophysical properties of a fibrin gel could simultaneously regulate the proangiogenic and osteogenic potential of entrapped MSCs. Fibrin gels were formed by supplementation with NaCl (1.2, 2.3, and 3.9% w/v) to modulate gel biophysical properties without altering protein concentrations. MSCs entrapped in 1.2% w/v NaCl gels were the most proangiogenic in vitro, yet cells in 3.9% w/v gels exhibited the greatest osteogenic response. Compared to the other groups, MSCs entrapped in 2.3% w/v gels provided the best balance between proangiogenic potential, osteogenic potential, and gel contractility. The contribution of MSCs to bone repair was then examined when deployed in 2.3% w/v NaCl gels and implanted into an irradiated orthotopic bone defect. Compared to acellular gels after 3 weeks of implantation, defects treated with MSC-loaded fibrin gels exhibited significant increases in vessel density, early osteogenesis, superior morphology, and increased cellularity of repair tissue. Defects treated with MSC-loaded gels exhibited increased bone formation after 12 weeks compared to blank gels. These results confirm that fibrin gel properties can be modulated to simultaneously promote both the proangiogenic and osteogenic potential of MSCs, and fibrin gels modified by supplementation with NaCl are promising carriers for MSCs to stimulate bone repair in vivo.
间充质干/基质细胞(MSCs)正在接受检验,以用于细胞疗法来修复因创伤或疾病导致的骨缺损。MSCs分泌促血管生成信号,并且可以被诱导分化为形成骨的成骨细胞,但仅有有限的证据表明这些过程可以同时实现。操纵细胞递送载体的特性是一种指导MSCs在骨愈合中发挥功能的候选方法。我们假设纤维蛋白凝胶的生物物理特性可以同时调节包裹在其中的MSCs的促血管生成和骨生成潜力。通过添加NaCl(1.2%、2.3%和3.9% w/v)形成纤维蛋白凝胶,以调节凝胶的生物物理特性而不改变蛋白质浓度。包裹在1.2% w/v NaCl凝胶中的MSCs在体外具有最强的促血管生成能力,而包裹在3.9% w/v凝胶中的细胞表现出最大的成骨反应。与其他组相比,包裹在2.3% w/v凝胶中的MSCs在促血管生成潜力、成骨潜力和凝胶收缩性之间提供了最佳平衡。然后,当将包裹在2.3% w/v NaCl凝胶中的MSCs植入受辐照的原位骨缺损中时,研究了MSCs对骨修复的贡献。与植入3周后的无细胞凝胶相比,用负载MSCs的纤维蛋白凝胶治疗的缺损在血管密度、早期骨生成、更好的形态以及修复组织细胞数量增加方面均有显著增加。与空白凝胶相比,用负载MSCs的凝胶治疗的缺损在12周后骨形成增加。这些结果证实,可以调节纤维蛋白凝胶的特性以同时促进MSCs的促血管生成和成骨潜力,并且通过添加NaCl修饰的纤维蛋白凝胶是MSCs在体内刺激骨修复的有前景的载体。